Contract 75A50120C00001
Paratek Pharmaceuticals, Inc · Department Of Health And Human Services · December 18, 2019
Paratek Pharmaceuticals, Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on December 18, 2019 for $265.32 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. It was awarded under full and open competition. The contract has been modified 13 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 20, 2026.
Contract details
- PIID
- 75A50120C00001
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Drugs And Biologicals
- Place of performance
- Boston, MA
- First action
- December 18, 2019
- Latest action
- February 20, 2026
Description
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
Modification timeline
-
February 20, 2026Mod P00013$0
-
February 19, 2026Mod P00012$17.47M
-
March 31, 2025Mod P00011$4.96M
-
February 27, 2025Mod P00010$0
-
December 11, 2024Mod P00009$0
-
June 17, 2024Mod P00008$0
-
February 6, 2024Mod P00007$17.47M
-
November 29, 2023Mod P00006$808.0K
-
June 28, 2023Mod P00005$0
-
December 15, 2022Mod P00004$36.40M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00001?
Contract 75A50120C00001 is a federal contract awarded to Paratek Pharmaceuticals, Inc by Department Of Health And Human Services on December 18, 2019 for $265.32 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 13 times since the base award.
Who won contract 75A50120C00001?
Paratek Pharmaceuticals, Inc won contract 75A50120C00001 from Department Of Health And Human Services.
How much is contract 75A50120C00001 worth?
Contract 75A50120C00001 has obligated $265.32 million to date, with a total potential value of $303.75 million if all options are exercised.